Prevalence of Refractive Errors in Primary School Children

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05781997
Collaborator
(none)
500
4

Study Details

Study Description

Brief Summary

The study aim to determine the prevalence of refractive errors in primary school children aged 6-12 in The New Valley , Egypt .

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: cycloplegic refraction

Detailed Description

The refractive state of the eye changes as the eye's axial length increases and the cornea and lens flattens. In general, eyes are hyperopic at birth, and become slightly more hyperopic until the age of 7, at this point we see a myopic shift toward Plano until the eyes reach their adult dimensions, usually by about the age of 16.

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prevalence of Refractive Errors in Primary School Children in The New Valley
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Outcome Measures

Primary Outcome Measures

  1. prevalence of refractive error in primary school children [baseline]

    determine the prevalence of refractive error in primary school children aged 6-12 in New Valley, Egypt .

Secondary Outcome Measures

  1. Degree of Visual aquity improvement of children. [Baseline]

    We need to measure : 1-Degree of improvement of visual aquity among those children . 2 - Acceptence of the parents and children to wear spectecles among those population .

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 12 Years
Sexes Eligible for Study:
All
Inclusion Criteria:

Age: 6 -12-year-old Myopia :- 0.5 D to -10D Hypermetropia: 1 D to 8 D Astigmatism: 0 to 6 D Distance correction: 0.1 logs MAR (20/25 ) or better

Exclusion Criteria:

Retinopathy, Prematurity, history of genetic disease, connective tissue diseases (e.g. Stickler or Marfan syndromes, any ocular diseases, Glaucoma, Cataract, Squint.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

  • Study Director: Omar Mo Ali, Professor, supervisor
  • Study Director: Ahmed Mh fahmy, AssProfessor, supervisor
  • Study Director: Mohammed An Sayed, Lecturer, supervisor
  • Principal Investigator: Doaa An Mohammed, Resident, Investigator

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Doaa Anwar Mohamed Said, Mut ,The New Valley , Egypt, Assiut University
ClinicalTrials.gov Identifier:
NCT05781997
Other Study ID Numbers:
  • refractive errors
First Posted:
Mar 23, 2023
Last Update Posted:
Mar 23, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 23, 2023